Bryn Mawr Trust CO Organon & Co. Transaction History

Bryn Mawr Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $497,583 - $643,181	-16,341 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$28.67 - $37.13 $34,432 - $44,593	-1,201 Reduced 6.85%	16,341 $497,000
Q3 2021 Oct 26, 2021	SELL	$28.63 - $35.64 $55,198 - $68,713	-1,928 Reduced 9.9%	17,542 $574,000
Q2 2021 Jul 29, 2021	BUY	$28.45 - $38.0 $553,921 - $739,860	19,470 New	19,470 $589,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

Stay updated on Bryn Mawr Trust CO with notifications on news.